drugset / Trial / NCT03132610

A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic Bronchitis

NCT03132610

Phase 4 Unknown 240 enrolled Jiangxi Qingfeng Pharmaceutical Co. Ltd.
RandomizedParallel-groupSingle-blindTreatment

Summary

A multicenter,randomized,single-blind, placebo-controlled,phase 4 clinical trial to evaluate the efficacy and safety of andrographolide sulfonate in patients with acute exacerbation of chronic bronchitis

Timeline

Start
2016-12-01
Primary completion
2017-12-01
Completion
2018-06-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator andrographolide sulfonate Unknown 10 ml Intravenous
Comparator andrographolide sulfonate Unknown 20 ml Intravenous

Indications